Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Lupin Limited ( (IN:LUPIN)) just unveiled ...

The last 12 months have been a bit boring for Novartis AG (NYSE:NVS) and have resulted in a lack of my coverage updates on the company. The stock has delivered a total return of around 18% since my ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Over the past six months, numerous pharmaceutical companies have announced plans to invest in new U.S. manufacturing facilities within the next decade. This so-called “onshoring,” motivated by the ...

WASHINGTON -- Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and ...

Marion Bradley, 57, filling a prescription for one of her customers . She is the lead pharmacist and co-owner of Beacon Falls Pharmacy. Credit: Carl Jordan Castro / C-HIT.org CT Mirror’s independent, ...

Donald Trump's warning of a 100% tariff on branded and patented pharmaceutical products has set the industry buzzing. While Indian pharma exports to the US totalled $10.5 billion in 2024–25, only $1 ...

Biosimilars and generics drive significant health care savings, yet a concerning lack of biosimilar development for biologics set to lose exclusivity in the next 10 years threatens future access and ...

Abbott ABT has consistently demonstrated strong growth and gained market share within its Nutrition business. Its Diabetes Care business continues to benefit from the growing sales of its flagship, ...

With Rinvoq and its sibling medicine Skyrizi having successfully picked up the sales torch in the wake of Humira’s tumble over the patent cliff, AbbVie is working to cover its legal bases so the ...

The biopharmaceutical company doesn't expect U.S. generic entry for the drug before 2037 now that it has settled litigation. Kroger Lifts Outlook as Quarterly Sales Edge Higher Kroger raised its ...